{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:05:19Z","timestamp":1780067119894,"version":"3.54.0"},"reference-count":19,"publisher":"Polish Society of Microbiologists","issue":"2","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Retrospective analysis of\n                    <jats:italic>Streptococcus agalactiae<\/jats:italic>\n                    antibiotic susceptibility isolated in 2010\u20132013 was performed. Penicillin was still the firstline antibiotic. Due to the high percentage of strains resistant to erythromycin and clindamycin empirical treatment with these antibiotics may not be effective. Lower resistance rate to erythromycin and clindamycin among strains isolated from infected pregnant women and newborns were observed than among strains isolated from samples from patients hospitalized in other departments (29% and 47% v. 46% and 63%). The increasing resistance rate might give a rise to a new epidemiological situation.\n                  <\/jats:p>","DOI":"10.5604\/01.3001.0010.7878","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T11:32:50Z","timestamp":1515497570000},"page":"265-268","source":"Crossref","is-referenced-by-count":1,"title":["Erythromycin or Clindamycin \u2013 is it Still an Empirical Therapy against\n                    <i>Streptococcus agalactiae<\/i>\n                    in Patients Allergic to Penicillin?"],"prefix":"10.33073","volume":"66","author":[{"given":"PIOTR","family":"LESZCZY\u0143SKI","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology , Warsaw Medical University of Warsaw , Warsaw , Poland"},{"name":"Hospital Infection Control Team , Infant Jesus University Hospital , Warsaw , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BEATA","family":"SOK\u00d3\u0141-LESZCZY\u0143SKA","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology , Warsaw Medical University of Warsaw , Warsaw , Poland"},{"name":"Department of Medical Microbiology , Infant Jesus University Hospital , Warsaw , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BRONIS\u0141AWA","family":"PIETRZAK","sequence":"additional","affiliation":[{"name":"I Department of Obstetrics and Gynecology , Medical University of Warsaw , Warsaw , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANNA","family":"SAWICKA-GRZELAK","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology , Warsaw Medical University of Warsaw , Warsaw , Poland"},{"name":"Department of Medical Microbiology , Infant Jesus University Hospital , Warsaw , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MIROS\u0141AW","family":"WIELGO\u015a","sequence":"additional","affiliation":[{"name":"I Department of Obstetrics and Gynecology , Medical University of Warsaw , Warsaw , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18083","published-online":{"date-parts":[[2017,6,28]]},"reference":[{"key":"2026052913575155830_j_01.3001.0010.7878_ref_001","doi-asserted-by":"crossref","unstructured":"Abdelazim I.A. 2013. Intrapartum polymerase chain reaction for detection of group B Streptococcus colonisation. Aust. NZJ Obstet. Gynaecol. 53(3): 236\u2013242.","DOI":"10.1111\/ajo.12030"},{"key":"2026052913575155830_j_01.3001.0010.7878_ref_002","unstructured":"Arana D.M., B.R. Bezares and C.T. Manrique. 2014. First clinical isolate in Europe of clindamycin-resistant group B Streptococcus mediated by the lnu (B) gene. Rev. Esp. Qui 27(2): 106\u2013109."},{"key":"2026052913575155830_j_01.3001.0010.7878_ref_003","unstructured":"Bigos M., M. \u0141ysakowska and M. Wasiela. 2012. Perinatal infections of etiology Streptococcus agalactiae (in Polish). Post. Mikrobiol. 51(4): 299\u2013308."},{"key":"2026052913575155830_j_01.3001.0010.7878_ref_004","unstructured":"Brown H.L., H.K. Ahmadzia and R.P. Heine. 2013. GBS Screening: An update on guidelines and methods. http:\/\/contemporaryobgyn.modernmedicine.com\/contemporary-obgyn\/content\/tags\/bd-geneohm\/gbs-screening-update-guidelines-and-methods, 2016.04.18."},{"key":"2026052913575155830_j_01.3001.0010.7878_ref_005","doi-asserted-by":"crossref","unstructured":"Church D.L., H. Baxter and T. Lloyd. 2011. Evaluation of the Xpert group B Streptococcus real-time polymerase chain reaction assay compared to StrepB Carrot Broth for the rapid intrapartum detection of group B streptococcus colonization. Diagn. Microbiol. Infect. Dis. 69: 460\u2013462.10.1016\/j.diagmicrobio.2010.11.00221396547","DOI":"10.1016\/j.diagmicrobio.2010.11.002"},{"key":"2026052913575155830_j_01.3001.0010.7878_ref_006","doi-asserted-by":"crossref","unstructured":"Clifford V., H.M. Heffernan and K. Grimwood. 2011. Variation in erythromycin and clindamycin resistance patterns between New Zealand and Australian group B Streptococcus isolates. NZJ Obstet. Gynaecol. 1(4): 328\u2013332.","DOI":"10.1111\/j.1479-828X.2011.01302.x"},{"key":"2026052913575155830_j_01.3001.0010.7878_ref_007","doi-asserted-by":"crossref","unstructured":"de-Paris F., A.B.M.P. Machado and T.C. Gheno. 2011. Group B Streptococcus detection: comparison of PCR assay and culture as a screening method for pregnant women. Braz. J. Infect. Dis. 15(4): 323\u2013327.","DOI":"10.1590\/S1413-86702011000400004"},{"key":"2026052913575155830_j_01.3001.0010.7878_ref_008","doi-asserted-by":"crossref","unstructured":"Di Renzo G.C., P. Melin and A. Berardi. 2015. Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference. J. Matern. Fetal. Neonatal. Med. 28(7): 766\u2013778.","DOI":"10.3109\/14767058.2014.934804"},{"key":"2026052913575155830_j_01.3001.0010.7878_ref_009","doi-asserted-by":"crossref","unstructured":"Edwards R.K., P. Clark and P. Duff. 2002. Intrapartum antibiotic prophylaxis 2: positive predictive value of antenatal group B streptococci cultures and antibiotic susceptibility of clinical isolates. Obstet. Gynecol. 100: 540\u2013544.10.1097\/00006250-200209000-00022","DOI":"10.1097\/00006250-200209000-00022"},{"key":"2026052913575155830_j_01.3001.0010.7878_ref_010","doi-asserted-by":"crossref","unstructured":"Helali N.E., Y. Giovangrandi and K. Guyot. 2012. Cost and effectiveness of intrapartum group B Streptococcus polymerase chain reaction screening for term deliveries. Obstet. Gynecol. 119: 822\u2013829.10.1097\/AOG.0b013e31824b146122433346","DOI":"10.1097\/AOG.0b013e31824b1461"},{"key":"2026052913575155830_j_01.3001.0010.7878_ref_011","doi-asserted-by":"crossref","unstructured":"Kasahara K., A.K. Baltus and S.H. Lee. 2010. Prevalence of nonpenicillin-susceptible group B Streptococcus in Philadelphia and specificity of penicillin resistance screening methods. J. Clin. Microb. 48 (4): 1468\u20131469.","DOI":"10.1128\/JCM.02296-09"},{"key":"2026052913575155830_j_01.3001.0010.7878_ref_012","unstructured":"National Institute for Health and Care Excellence. 2015. Xpert GBS test for the intrapartum detection of group B Streptococcus https:\/\/www.nice.org.uk\/advice\/mib28\/resources\/xpert-gbs-test-for-the-intrapartum-detection-of-group-b-streptococcus-63499051847365, 2016.04.18."},{"key":"2026052913575155830_j_01.3001.0010.7878_ref_013","doi-asserted-by":"crossref","unstructured":"Poncelet-Jasserand E., F. Forges and M.N. Varlet. 2013. Reduction of the use of antimicrobial drugs following the rapid detection of Streptococcus agalactiae in the vagina at delivery by real-time PCR assay. BJOG 120: 1098\u20131108.10.1111\/1471-0528.1213823656626","DOI":"10.1111\/1471-0528.12138"},{"key":"2026052913575155830_j_01.3001.0010.7878_ref_014","unstructured":"Savini V., R. Marrollo and M. D\u2019Antonio. 2013. Case Report. Streptococcus agalactiae vaginitis: nonhemolytic variant on the Liofilchem Chromatic StreptoB. Int. J. Clin. Exp. Pathol. 6(8): 1693\u20131695."},{"key":"2026052913575155830_j_01.3001.0010.7878_ref_015","doi-asserted-by":"crossref","unstructured":"Seo Y.S., U. Srinivasan and K.Y. Oh. 2010. Changing molecular epidemiology of group B Streptococcus in Korea. J. Korean Med. Sci. 25: 817\u2013823.10.3346\/jkms.2010.25.6.817287722320514299","DOI":"10.3346\/jkms.2010.25.6.817"},{"key":"2026052913575155830_j_01.3001.0010.7878_ref_016","doi-asserted-by":"crossref","unstructured":"Srinivasan V., B.J. Metcalf and K.M. Knipe. 2014. Van G element insertions within a conserved chromosomal site conferring vancomycin resistance to Streptococcus agalactiae and Streptococcus anginosus. mBio 5(4): e01386\u201314.10.1128\/mBio.01386-14412019825053786","DOI":"10.1128\/mBio.01386-14"},{"key":"2026052913575155830_j_01.3001.0010.7878_ref_017","doi-asserted-by":"crossref","unstructured":"Szymusik I., K. Kosi\u0144ska-Kaczy\u0144ska and B .Pietrzak. 2014. Is it time for a change in screening for GBS carriage? (in Polish). Ginekol. Pol. 85: 456\u2013460.10.17772\/gp\/175325029812","DOI":"10.17772\/gp\/1753"},{"key":"2026052913575155830_j_01.3001.0010.7878_ref_018","unstructured":"Verani J.R., L. McGee and S.J. Schrag. 2010. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010. MMWR 59(RR10): 1\u201332."},{"key":"2026052913575155830_j_01.3001.0010.7878_ref_019","doi-asserted-by":"crossref","unstructured":"Verani J.R. and S.J. Schrag. 2010. Group B streptococcal disease in infants: progress in prevention and continued challenges. Clin. Perinat. 37: 375\u2013392.10.1016\/j.clp.2010.02.00220569813","DOI":"10.1016\/j.clp.2010.02.002"}],"container-title":["Polish Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pjm-microbiology.publisherspanel.com\/gicid\/pdf\/01.3001.0010.7878","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/reference-global.com\/pdf\/10.5604\/01.3001.0010.7878","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T14:19:29Z","timestamp":1780064369000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.5604\/01.3001.0010.7878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,1]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,6,28]]},"published-print":{"date-parts":[[2017,1,1]]}},"alternative-id":["10.5604\/01.3001.0010.7878"],"URL":"https:\/\/doi.org\/10.5604\/01.3001.0010.7878","relation":{},"ISSN":["2544-4646"],"issn-type":[{"value":"2544-4646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,1]]}}}